{"symbol":"ABT","fiscalQuarter":"Q4-2023","reportDate":"2024-01-24","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q4-2023","postBrief":{"headline":"Abbott Labs Meets EPS Expectations, Stock Down 2.83%","keyNumbers":[{"metric":"EPS","actual":"$1.19","expected":"N/A","surprise":"+0.00%"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management highlighted stability in core product lines.","They noted ongoing challenges in certain market segments."],"summary":"Overall, management expressed a steady outlook but acknowledged some market pressures. There was no significant change in their strategic direction."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported earnings that met expectations for EPS, but the stock fell by 2.83% following the announcement. The decline may reflect investor concerns about market challenges and the lack of new guidance. Overall, the company seems to be maintaining stability, but uncertainty remains in certain areas.","metaDescription":"Abbott Labs (ABT) Q4 2023 earnings: EPS met expectations. Stock down 2.83%. Full breakdown."}}